601 - 625 of 6258 Results
Title
Year
-
OPENTitle: Reduced glucocerebrosidase activity in monocytes from patients with Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-018-33921-xBest OA location URL: https://www.nature.com/articles/s41598-018-33921-x.pdfCitation Count: 102
- Computational affinity maturation of camelid single-domain intrabodies against the nonamyloid component of alpha-synuclein2018OPENTitle: Computational affinity maturation of camelid single-domain intrabodies against the nonamyloid component of alpha-synucleinJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-018-35464-7Best OA location URL: https://www.nature.com/articles/s41598-018-35464-7.pdfCitation Count: 40
- Association of multiple sclerosis with restless legs syndrome and other sleep disorders in women2012OPENTitle: Association of multiple sclerosis with restless legs syndrome and other sleep disorders in womenJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 78Issue #: 19Start Page: 1500End Page: 1506Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182553c5bBest OA location URL: https://n.neurology.org/content/neurology/78/19/1500.full.pdfCitation Count: 66
-
OPENTitle: Bid signal pathway components are identified in the temporal cortex with Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 79Issue #: 17Start Page: 1767End Page: 1773Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182703f76Best OA location URL: https://n.neurology.org/content/neurology/79/17/1767.full.pdfCitation Count: 17
-
OPENTitle: Neurologist-associated reduction in PD-related hospitalizations and health care expendituresJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 79Issue #: 17Start Page: 1774End Page: 1780Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182703f92Best OA location URL: https://n.neurology.org/content/neurology/79/17/1774.full.pdfCitation Count: 98
-
OPENTitle: Prospective cohort study of spinal muscular atrophy types 2 and 3Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 79Issue #: 18Start Page: 1889End Page: 1897Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318271f7e4Best OA location URL: https://n.neurology.org/content/neurology/79/18/1889.full.pdfCitation Count: 252
- Global quantitative analysis of the human brain proteome in Alzheimer’s and Parkinson’s Disease2018OPENTitle: Global quantitative analysis of the human brain proteome in Alzheimer’s and Parkinson’s DiseaseJournal Name: Scientific DataPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/sdata.2018.36Best OA location URL: https://www.nature.com/articles/sdata201836.pdfCitation Count: 214
-
OPENTitle: Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patientsJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 80Issue #: 18Start Page: 1698End Page: 1701Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182904faaBest OA location URL: https://n.neurology.org/content/neurology/80/18/1698.full.pdfCitation Count: 197
- Activation of acid-sensing ion channels by localized proton transient reveals their role in proton signaling2015OPENTitle: Activation of acid-sensing ion channels by localized proton transient reveals their role in proton signalingJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/srep14125Best OA location URL: https://www.nature.com/articles/srep14125.pdfCitation Count: 38
- GTP binding and intramolecular regulation by the ROC domain of Death Associated Protein Kinase 12012OPENTitle: GTP binding and intramolecular regulation by the ROC domain of Death Associated Protein Kinase 1Journal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/srep00695Best OA location URL: https://www.nature.com/articles/srep00695.pdfCitation Count: 12
- Integration of transcriptomic and genomic data suggests candidate mechanisms for APOE4-mediated pathogenic action in Alzheimer’s disease2016OPENTitle: Integration of transcriptomic and genomic data suggests candidate mechanisms for APOE4-mediated pathogenic action in Alzheimer’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/srep32583Best OA location URL: https://www.nature.com/articles/srep32583.pdfCitation Count: 22
-
OPENTitle: n-3 PUFA supplementation benefits microglial responses to myelin pathologyJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1038/srep07458Best OA location URL: https://www.nature.com/articles/srep07458.pdfCitation Count: 130
- A novel resource for studying function and dysfunction of α-synuclein: mouse lines for modulation of endogenous Snca gene expression2015OPENTitle: A novel resource for studying function and dysfunction of α-synuclein: mouse lines for modulation of endogenous Snca gene expressionJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/srep16615Best OA location URL: https://www.nature.com/articles/srep16615.pdfCitation Count: 25
- Activation of the unfolded protein response promotes axonal regeneration after peripheral nerve injury2016OPENTitle: Activation of the unfolded protein response promotes axonal regeneration after peripheral nerve injuryJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/srep21709Best OA location URL: https://www.nature.com/articles/srep21709.pdfCitation Count: 91
- Inhibitor treatment of peripheral mononuclear cells from Parkinson’s disease patients further validates LRRK2 dephosphorylation as a pharmacodynamic biomarker2016OPENTitle: Inhibitor treatment of peripheral mononuclear cells from Parkinson’s disease patients further validates LRRK2 dephosphorylation as a pharmacodynamic biomarkerJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/srep31391Best OA location URL: https://www.nature.com/articles/srep31391.pdfCitation Count: 260
- Relative vascular permeability and vascularity across different regions of the rat nasal mucosa: implications for nasal physiology and drug delivery2016OPENTitle: Relative vascular permeability and vascularity across different regions of the rat nasal mucosa: implications for nasal physiology and drug deliveryJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/srep31732Best OA location URL: https://www.nature.com/articles/srep31732.pdfCitation Count: 52
- Amyloid oligomer interactions and polymorphisms: disease-relevant distinct assembly of α-synuclein and tau2018OPENTitle: Amyloid oligomer interactions and polymorphisms: disease-relevant distinct assembly of α-synuclein and tauJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 44Issue #: 1Start Page: 222End Page: 223Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41386-018-0204-8Best OA location URL: https://www.nature.com/articles/s41386-018-0204-8.pdfCitation Count: 1
- Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease2011OPENTitle: Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 71Issue #: 4Start Page: 560End Page: 568Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.22691Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.22691Citation Count: 238
-
OPENTitle: Head injury, alpha‐synuclein Rep1, and Parkinson's diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 71Issue #: 1Start Page: 40End Page: 48Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.22499Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3270814Citation Count: 95
-
OPENTitle: Future of cell and gene therapies for Parkinson's diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 64Issue #: S2Start Page: S122End Page: S138Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.21473Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3982797Citation Count: 53
- 18F‐flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study2017OPENTitle: 18F‐flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter studyJournal Name: Annals of NeurologyPublisher: WileyVol: 82Issue #: 4Start Page: 622End Page: 634Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25060Best OA location URL: https://escholarship.org/uc/item/01j9450zCitation Count: 164
-
OPENTitle: Solvent exposures and parkinson disease risk in twinsJournal Name: Annals of NeurologyPublisher: WileyVol: 71Issue #: 6Start Page: 776End Page: 784Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.22629Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.22629Citation Count: 166
-
OPENTitle: N‐acetylcysteine prevents loss of dopaminergic neurons in the EAAC1−/− mouseJournal Name: Annals of NeurologyPublisher: WileyVol: 69Issue #: 3Start Page: 509End Page: 520Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.22162Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.22162Citation Count: 130
-
OPENTitle: Neuron‐to‐neuron transmission of α‐synuclein fibrils through axonal transportJournal Name: Annals of NeurologyPublisher: WileyVol: 72Issue #: 4Start Page: 517End Page: 524Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.23747Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3490229Citation Count: 333
- Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action.2013OPENTitle: Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action.Journal Name: Anti-Inflammatory & Anti-Allergy Agents in Medicinal ChemistryPublisher: Bentham Science Publishers Ltd.Vol: 12Issue #: 2Start Page: 117End Page: 128Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/1871523011312020003Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5214460Citation Count: 26